Reprogrammed TREM2^(+) macrophages drive nonresolving inflammation in peripheral artery disease associated with type 2 diabetes (Malhi et al., this issue).
Sci Transl Med. 2026 Apr 22;18(846):eaef8756. doi: 10.1126/scitranslmed.aef8756. Epub 2026 Apr 22.
ABSTRACT
Reprogrammed TREM2+ macrophages drive nonresolving inflammation in peripheral artery disease associated with type 2 diabetes (Malhi et al., this issue).
PMID:42018667 | DOI:10.1126/scitranslmed.aef8756